Canada, Novartis Issue Warning On Blood Pressure Drugs
Canada's health regulator and Novartis Pharmaceuticals Canada Inc. warned consumers Monday that blood pressure drugs Rasilez and Rasilez HCT could increase the risk of strokes and other health problems in patients...To view the full article, register now.
Already a subscriber? Click here to view full article